Procter & Gamble

Should I buy Procter & Gamble stock in 2025?

Is Procter & Gamble stock a buy right now?

Last update: 30 May 2025
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
P. Laurore
P. LauroreFinance expert

Procter & Gamble (PG), a flagship in the global consumer staples sector, is currently trading near $168.56 on the NYSE, with a robust average daily trading volume of 8.59 million shares. Despite navigating a challenging consumer environment, PG continues to demonstrate resilience and operational strength: its latest quarterly results outperformed profit expectations (EPS of $1.54 versus $1.53 forecasted), even as sales volumes faced headwinds. The company recently returned $3.8 billion to shareholders, underscoring both its confidence and strong cash flows. Sector-wide, the defensive positioning of household and personal products has offered investors relative shelter from recent market volatility, and Procter & Gamble’s continued innovation and global portfolio stand out among peers. Notably, the consensus among 34 leading national and international banks sets a target price at $219.13 per share, underlining the market’s constructive medium-term sentiment. For Irish investors, in particular, PG's mix of reliable dividends, world-class brands, and low beta (0.41) present an appealing option for portfolio stability. With steady expansion in emerging markets and disciplined capital returns, now may be a sensible moment for investors seeking defensive growth and reliable income within this essential sector.

  • Stable global leader with over $395B market cap and iconic consumer brands.
  • Attractive 2.51% dividend yield and a record of consistent shareholder returns.
  • Demonstrated pricing power supports robust margins and outperformance in earnings.
  • Expansive distribution network and ongoing strategic investment in emerging markets.
  • Defensive, low-beta profile (0.41) tempers volatility, ideal for long-term portfolios.
  • Recent sales growth remains modest amid persistent macroeconomic pressures.
  • Exposure to currency fluctuations and higher raw material costs may weigh on margins.
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
  • Stable global leader with over $395B market cap and iconic consumer brands.
  • Attractive 2.51% dividend yield and a record of consistent shareholder returns.
  • Demonstrated pricing power supports robust margins and outperformance in earnings.
  • Expansive distribution network and ongoing strategic investment in emerging markets.
  • Defensive, low-beta profile (0.41) tempers volatility, ideal for long-term portfolios.

Is Procter & Gamble stock a buy right now?

Last update: 30 May 2025
P. Laurore
P. LauroreFinance expert
  • Stable global leader with over $395B market cap and iconic consumer brands.
  • Attractive 2.51% dividend yield and a record of consistent shareholder returns.
  • Demonstrated pricing power supports robust margins and outperformance in earnings.
  • Expansive distribution network and ongoing strategic investment in emerging markets.
  • Defensive, low-beta profile (0.41) tempers volatility, ideal for long-term portfolios.
  • Recent sales growth remains modest amid persistent macroeconomic pressures.
  • Exposure to currency fluctuations and higher raw material costs may weigh on margins.
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
Procter & GambleProcter & Gamble
4.3
hellosafe-logoScore
  • Stable global leader with over $395B market cap and iconic consumer brands.
  • Attractive 2.51% dividend yield and a record of consistent shareholder returns.
  • Demonstrated pricing power supports robust margins and outperformance in earnings.
  • Expansive distribution network and ongoing strategic investment in emerging markets.
  • Defensive, low-beta profile (0.41) tempers volatility, ideal for long-term portfolios.
Procter & Gamble (PG), a flagship in the global consumer staples sector, is currently trading near $168.56 on the NYSE, with a robust average daily trading volume of 8.59 million shares. Despite navigating a challenging consumer environment, PG continues to demonstrate resilience and operational strength: its latest quarterly results outperformed profit expectations (EPS of $1.54 versus $1.53 forecasted), even as sales volumes faced headwinds. The company recently returned $3.8 billion to shareholders, underscoring both its confidence and strong cash flows. Sector-wide, the defensive positioning of household and personal products has offered investors relative shelter from recent market volatility, and Procter & Gamble’s continued innovation and global portfolio stand out among peers. Notably, the consensus among 34 leading national and international banks sets a target price at $219.13 per share, underlining the market’s constructive medium-term sentiment. For Irish investors, in particular, PG's mix of reliable dividends, world-class brands, and low beta (0.41) present an appealing option for portfolio stability. With steady expansion in emerging markets and disciplined capital returns, now may be a sensible moment for investors seeking defensive growth and reliable income within this essential sector.
Table of Contents
  • What is Procter & Gamble?
  • How much is Procter & Gamble stock?
  • Our full analysis of the Procter & Gamble stock
  • How to buy Procter & Gamble stock in Ireland?
  • Our 7 tips for buying Procter & Gamble stock
  • The latest news about Procter & Gamble
  • FAQ

What is Procter & Gamble?

IndicatorValueAnalysis
🏳️ NationalityUnited StatesUS-based, ensures high regulatory standards and strong access to capital markets.
💼 MarketNYSE (New York Stock Exchange)Globally recognized exchange; ensures liquidity and transparency for investors.
🏛️ ISIN codeUS7427181091Unique international identifier, essential for secure trades and compliance.
👤 CEOJon R. MoellerCEO since 2021, focusing on sustainable growth and brand leadership.
🏢 Market cap$395.20 billionLarge cap signals stability; suitable for risk-averse and income-focused investors.
📈 Revenue$19.78 billion (Q3 FY2025)Quarterly sales slightly dropped; reflects tough consumer environment and currency effects.
💹 EBITDA~$5.0 billion* (Q3 FY2025, estimated)Strong cash generation supports ongoing dividends and investment in new products.
📊 P/E Ratio (Price/Earnings)26.76Higher than sector average; reflects market's confidence in stable future earnings.
🏳️ Nationality
Value
United States
Analysis
US-based, ensures high regulatory standards and strong access to capital markets.
💼 Market
Value
NYSE (New York Stock Exchange)
Analysis
Globally recognized exchange; ensures liquidity and transparency for investors.
🏛️ ISIN code
Value
US7427181091
Analysis
Unique international identifier, essential for secure trades and compliance.
👤 CEO
Value
Jon R. Moeller
Analysis
CEO since 2021, focusing on sustainable growth and brand leadership.
🏢 Market cap
Value
$395.20 billion
Analysis
Large cap signals stability; suitable for risk-averse and income-focused investors.
📈 Revenue
Value
$19.78 billion (Q3 FY2025)
Analysis
Quarterly sales slightly dropped; reflects tough consumer environment and currency effects.
💹 EBITDA
Value
~$5.0 billion* (Q3 FY2025, estimated)
Analysis
Strong cash generation supports ongoing dividends and investment in new products.
📊 P/E Ratio (Price/Earnings)
Value
26.76
Analysis
Higher than sector average; reflects market's confidence in stable future earnings.

*Note: EBITDA is estimated from net income and margin data, as not directly provided.

How much is Procter & Gamble stock?

The price of Procter & Gamble stock is rising this week. As of now, PG trades at $168.56, up $1.20 (+0.72%) in the past 24 hours and showing a weekly gain of 1.89%.

Market Capitalisation$395.20 billion
Average 3-Month Daily Volume8.59 million shares
P/E Ratio26.76
Dividend Yield2.51%
Stock Beta0.41
Average 3-Month Daily Volume
$395.20 billion
8.59 million shares
P/E Ratio
$395.20 billion
26.76
Dividend Yield
$395.20 billion
2.51%
Stock Beta
$395.20 billion
0.41

With its modest volatility and defensive profile, PG remains a reliable option for investors seeking steady growth in the Irish market.

Compare the finest brokers in Ireland and find the best one for you!Compare brokers

Our full analysis of the Procter & Gamble stock

Having thoroughly reviewed Procter & Gamble’s latest quarterly financials and assessed its share performance over the past three years, we have applied a rigorous multi-source analytical framework—incorporating core fundamentals, technical signals, and sector positioning compared to key peers—to extract actionable insights. Our proprietary algorithms have triangulated data from global markets, macroeconomic indicators, and industry benchmarks, delivering a clear view of where Procter & Gamble stands as we turn towards 2025. So, why might Procter & Gamble stock once again become a strategic entry point into the global consumer staples sector in 2025?

Recent Performance and Market Context

Procter & Gamble (PG) currently trades at $168.56 (as of 30 May 2025), reflecting a solid +4.27% gain over the past twelve months and a healthy 1.89% weekly improvement. While the share price is modestly lower on a 6-month basis (-5.97%), it now sits comfortably above the 52-week support levels, with its current range between $156.58 and $180.43. The most recent Q3 fiscal 2025 results delivered a slight outperformance on EPS ($1.54 actual vs. $1.53 expected) and demonstrated net income growth (+2.3% year-on-year) despite top-line revenue coming in just below consensus.

A vital strength for PG lies in the resilience of its global operations, anchored by leading brands such as Pampers, Tide, Gillette, and Olay—an asset classically prized during economic slowdowns. The company’s capacity to return capital to shareholders ($3.8B in Q3, with $2.4B via dividends alone) further reassures the market. As consumer confidence improves and the US dollar stabilises, the broader consumer defensive sector has found favour among investors seeking predictable revenue and robust cash flows—a trend highly relevant for Irish and European savers in 2025.

Technical Analysis

From a technical perspective, PG is exhibiting an increasingly constructive posture:

  • Relative Strength Index (RSI, 14 days): Currently at 57.25, this signals that the stock is comfortably within a balanced territory, with upside momentum well below the overbought zone—a classic precursor to medium-term advances.
  • MACD (Moving Average Convergence Divergence): The value at 0.36, sitting above the signal line, points to positive but unsaturated trend momentum.
  • Moving Averages: The 1-week and 1-day technical signals remain neutral, with price consolidating above the primary support zone ($155.33–$161.57), providing a “platform” effect for potential upward moves.
  • Key levels: $180.43 remains the 52-week resistance, marking a natural bullish target if sentiment accelerates.

Notably, recent price resilience near major supports, coupled with subdued volatility (5-year beta of 0.41), sets the stage for a new bullish phase as macro conditions turn more supportive.

Fundamental Analysis

PG’s underlying fundamentals provide a convincing case for renewed investor interest:

  • Revenue and Profitability: Q3 sales came in at $19.78B (-2% YoY), but net income rose to $3.77B (+2.3% YoY), validating management’s operational discipline even in a mixed demand environment. Adjusted free cash flow productivity is robust at 75%.
  • Earnings Quality and Dividends: EPS growth, albeit modest, outpaced expectations. The company’s 2.51% dividend yield (paying $4.23 per share annually) remains one of the most reliable in global equities, and dividend increments are a consistent feature.
  • Valuation: With a trailing P/E of 26.76 and a Price/Sales ratio below 5 (4.94), PG trades at a premium justified by persistent profitability (18.46% net margin), a 30.3% ROE, and a powerful legacy as a defensive income generator.

Strategically, Procter & Gamble’s innovation engine is relentless: continual product upgrades in fabric care, beauty, and health have safeguarded—and expanded—market share even as agile competitors seek to erode the moat. Its pricing power, brought by superb brand loyalty and global reach, allows the company to navigate or even capitalise on shifts in consumer behaviour.

Volume and Liquidity

Average daily volume hovers around 8.59 million shares, reflecting consistently high interest from both institutional and retail investors. This depth provides excellent liquidity and tight spreads—critical for dynamic portfolio management or for those seeking scale in their trading. With a public float of around 2.34 billion shares, the stock’s market depth underpins the potential for both organic and event-driven valuation realignment without liquidity constraints.

Catalysts and Positive Outlook

Looking ahead, several tangible and structural drivers suggest a positive trajectory for PG:

  • Product Innovation: Continuous launches and upgrades across premium and value segments drive growth resilience and defensiveness.
  • Geographical Expansion: Momentum remains strong in emerging markets, where rising middle-class demand lifts both volume and profit potential.
  • Sustainability & ESG Focus: Procter & Gamble has ramped up initiatives in sustainable sourcing, packaging, and operations—key factors increasingly priced into equity valuations by institutional investors, particularly from Europe and Ireland.
  • Defensive Sector Rotation: As macroeconomic uncertainty persists, global capital is favouring consumer staples—further enhancing the stock’s appeal for those seeking shelter from cyclical risk.

Upcoming earnings reports, new product rollouts, and continued return of capital (dividends and buybacks) serve as likely near-term catalysts. The sector’s regulatory and inflationary context also favours well-managed, diversified leaders like PG.

Investment Strategies

The current setup offers investor flexibility across multiple time horizons:

  • Short Term: The stock’s proximity to technical supports and recent neutral pattern allows for strategic entries with an immediate upside towards the $180.43 resistance. Short-term traders might view periods of consolidation around $160–$170 as optimal for tactical positioning ahead of earnings or new launches.
  • Medium Term: Macro tailwinds, sector flows, and innovation cycles suggest that any sustained breach of the $180 resistance could establish a new trading range closer to analysts’ upper price targets ($186 and above).
  • Long Term: For those with a multi-year horizon, buying PG offers a stable anchor, with the compounding of dividends and underlying growth—backstopped by unmatched brand equity and the company’s long record of weathering macro storms.

This constellation of technical, fundamental, and thematic support suggests that PG is entering a “low-risk, high-quality” phase, ideal for prudent yet opportunistic allocation.

Is it the Right Time to Buy Procter & Gamble?

In summary, Procter & Gamble’s combination of reliable dividend income, global brand leadership, strict fiscal stewardship, and proven defensive qualities make it exceptionally well-placed for current market conditions. The stock’s current valuation reflects both its defensive premium and its resilience in the face of modest sector growth, while technical signals and sustained liquidity point to a favourable entry window.

Analyst consensus, sector rotation, and a suite of positive catalysts mean that PG seems to represent an excellent opportunity for investors seeking both stability and upside potential as 2025 approaches. Whether for diversification, dividend income, or as a foundational defensive holding, the fundamentals and forward drivers justify renewed interest in this stalwart of the consumer staples universe.

With all the pieces in place—solid technical underpinnings, peerless brand equity, strong cash flow, and disciplined capital returns—Procter & Gamble stands out as a stock that could anchor both new and established portfolios seeking growth and security in a changing market landscape. Now, as the retail and institutional gaze once again shifts to safety, quality, and consistency, Procter & Gamble may be on the cusp of its next bullish phase—offering an opportunity that sophisticated investors would be wise to keep firmly on their horizon.

How to buy Procter & Gamble stock in Ireland?

Buying Procter & Gamble (PG) shares online is now a straightforward and secure process for investors in Ireland, thanks to regulation of reputable brokers in both the EU and US markets. You can choose between investing directly in PG stock for long-term ownership (spot buying), or trading contracts for difference (CFDs) for short-term strategies with leverage. Both opportunities are easily accessible from your computer or phone, with full transparency on costs and conditions. The key is selecting the right broker for your needs—see our broker comparison further down this page for help choosing wisely.

Spot buying

A cash (or spot) purchase of Procter & Gamble shares means you become a shareholder, owning real shares that give you the right to dividends and the potential for long-term growth. Most Irish-friendly brokers charge either a flat commission per order (typically €4–€10), or a small percentage of the transaction. Some US dollar transactions might also involve modest FX conversion fees.

icon

Example

Suppose the Procter & Gamble share price is $168.56 (approx. €156.20), and you wish to invest the equivalent of $1,000 (about €930). After a brokerage fee of around $5, you could buy approximately 5.9 shares (rounded down to 5 shares for simplicity).
✔️ Gain scenario:
If the share price rises by 10%, your shares are now worth $1,100.
Result: +$100 gross gain, or +10% on your investment, plus any dividends received during the holding period.

Trading via CFD

CFD trading allows you to speculate on the price movement of Procter & Gamble shares without actually owning them. Instead, you enter a contract with your broker based on the share's price changes. CFDs are suited to active traders, as you can use leverage (borrowed funds) to multiply your exposure—but remember, leverage increases both potential gains and risks. Fees typically include a spread (difference between buy and sell price) and overnight financing if you hold positions beyond a trading day.

icon

Example

With a $1,000 stake and 5x leverage, you open a CFD position on Procter & Gamble, giving you exposure to $5,000 worth of shares.
✔️ Gain scenario:
If the stock rises by 8%, your position gains 8% × 5 = 40%.
Result: +$400 gain on your $1,000 deposit (excluding spreads and financing fees).

Final advice

Before investing, it's crucial to compare the fees, features, and regulatory protections of different brokers—small differences can make a big impact over time. Your investment approach (long-term ownership vs. active trading) will determine which method is right for you. Take a look at our detailed broker comparison tool further down the page to find the ideal platform for your needs and objectives.

Compare the finest brokers in Ireland and find the best one for you!Compare brokers

Our 7 tips for buying Procter & Gamble stock

StepSpecific tip for Procter & Gamble
Analyse the marketReview Procter & Gamble’s position in the defensive consumer sector and study its performance trends, which are appealing for Irish investors seeking stability and resilience, especially during economic uncertainty.
Choose the right trading platformOpt for an Irish or EU-regulated trading platform that provides easy access to US shares like Procter & Gamble on the NYSE, ensuring competitive fees and efficient euro-to-dollar currency exchange.
Define your investment budgetDecide how much to allocate based on your risk appetite; as Procter & Gamble is a solid dividend payer, it can make up the core of a diversified, income-oriented portfolio.
Choose a strategy (short or long term)Considering P&G’s steady dividend growth and defensive characteristics, a long-term “buy and hold” approach typically aligns best with the stock’s historical performance.
Monitor news and financial resultsRegularly follow Procter & Gamble’s quarterly earnings, updates on brands like Pampers and Gillette, and major consumer trends to stay informed about factors impacting share price.
Use risk management toolsSet appropriate stop-loss orders and consider regular portfolio reviews to manage currency and market risk, given that P&G is traded in USD while Irish investors use EUR.
Sell at the right timeRe-evaluate your position during significant price increases or if P&G’s fundamentals materially change; consider selling if the stock surpasses major resistance levels or growth outlook weakens.
Analyse the market
Specific tip for Procter & Gamble
Review Procter & Gamble’s position in the defensive consumer sector and study its performance trends, which are appealing for Irish investors seeking stability and resilience, especially during economic uncertainty.
Choose the right trading platform
Specific tip for Procter & Gamble
Opt for an Irish or EU-regulated trading platform that provides easy access to US shares like Procter & Gamble on the NYSE, ensuring competitive fees and efficient euro-to-dollar currency exchange.
Define your investment budget
Specific tip for Procter & Gamble
Decide how much to allocate based on your risk appetite; as Procter & Gamble is a solid dividend payer, it can make up the core of a diversified, income-oriented portfolio.
Choose a strategy (short or long term)
Specific tip for Procter & Gamble
Considering P&G’s steady dividend growth and defensive characteristics, a long-term “buy and hold” approach typically aligns best with the stock’s historical performance.
Monitor news and financial results
Specific tip for Procter & Gamble
Regularly follow Procter & Gamble’s quarterly earnings, updates on brands like Pampers and Gillette, and major consumer trends to stay informed about factors impacting share price.
Use risk management tools
Specific tip for Procter & Gamble
Set appropriate stop-loss orders and consider regular portfolio reviews to manage currency and market risk, given that P&G is traded in USD while Irish investors use EUR.
Sell at the right time
Specific tip for Procter & Gamble
Re-evaluate your position during significant price increases or if P&G’s fundamentals materially change; consider selling if the stock surpasses major resistance levels or growth outlook weakens.

The latest news about Procter & Gamble

Procter & Gamble shares rose 1.89% this week, reflecting positive investor sentiment and solid defensive positioning. In the last seven days, P&G's stock price climbed to $168.56, buoyed by a resilient consumer staples sector and a strong reputation for stability—critical qualities valued by Irish and European investors amid volatile global markets. This uptick is notable as it contrasts with some broader market uncertainty, and further underscores the company's appeal for those seeking steady returns, such as pension funds and institutional managers based in Ireland.

The company delivered a robust quarterly net income, beating earnings expectations and supporting ongoing confidence in its fundamentals. P&G’s Q3 results, released in late April, saw net income rise by 2.3% year-on-year to $3.77 billion, and diluted EPS edged above forecasts, reaching $1.54 versus the anticipated $1.53. Though revenue slightly missed analyst targets, the company’s ability to maintain profitability and positive cash flow underlines the resilience of its core brands and global operations—an essential factor for long-term oriented Irish investors who value dividend safety and sustainable earnings.

P&G maintained an attractive dividend yield of 2.51% and continued significant shareholder returns, aligning with the preferences of income-focused Irish investors. Over the last quarter, the company returned $3.8 billion to shareholders, including $2.4 billion through dividends. This consistent dividend policy, featuring an annual yield of 2.51%, strongly appeals to Irish savers, fund managers, and retirees seeking reliable income streams, especially amidst low-yield environments. The dual focus on payouts and operational strength reinforces P&G’s suitability for conservative and income-oriented portfolios prevalent in Ireland.

The company’s strategic brand leadership and ongoing product innovation highlight continued relevance within the Irish market and the broader region. P&G’s portfolio, which includes major household names such as Tide, Pampers, Gillette, and Olay, remains widely distributed and deeply entrenched across Ireland’s retail and pharmacy channels. The group’s emphasis on premiumisation, regular product innovation, and robust distribution standards has helped sustain its competitive edge. This is especially pertinent as Irish consumers continue to favour established, quality brands in household and personal care.

Analyst consensus remains overweight, with technical indicators suggesting stable momentum and moderate upside potential for the stock. Recent months have brought analyst reiterations of P&G’s “Overweight” status, with a consensus target price near $173.81, compared to the current $168.56. Key technical signals, such as a neutral trend and healthy RSI, support the notion of underlying stability. These factors, along with the stock’s modest beta and defensive characteristics, offer reassurance to the Irish institutional and retail investment community about P&G’s ability to navigate both local and global headwinds.

FAQ

What is the latest dividend for Procter & Gamble stock?

Procter & Gamble currently pays a quarterly dividend. As of May 2025, the annual dividend amounts to $4.23 per share, with the most recent payment announced in April. This represents a yield of around 2.5%. P&G is renowned for its long history of increasing dividends, reflecting steady cash flow and a strong commitment to rewarding shareholders.

What is the forecast for Procter & Gamble stock in 2025, 2026, and 2027?

Based on recent valuations, the projected share price for Procter & Gamble is $219 at the end of 2025, $253 at the end of 2026, and $337 by the end of 2027. The company operates in a resilient consumer staples sector, supported by global brand leadership and continued product innovation. Analyst sentiment remains constructive, highlighting the stock’s underlying strengths.

Should I sell my Procter & Gamble shares?

Holding onto Procter & Gamble shares could be wise given the company’s defensive profile, solid dividend track record, and global portfolio of trusted brands. P&G’s ability to navigate challenging economic cycles and deliver steady results has historically reassured investors seeking stable growth. The stock’s fundamentals and sector positioning suggest it may remain a reliable choice for medium- to long-term portfolios.

How are Procter & Gamble dividends and capital gains taxed in Ireland?

For Irish residents, dividends from Procter & Gamble are subject to US withholding tax, typically at 15% if a tax treaty form is filed, and are also liable for Irish income tax. Capital gains from selling P&G shares are taxed under Irish Capital Gains Tax rules, with an annual exemption threshold. It's important to note that P&G shares are not eligible for Irish tax-free schemes like pensions or SSIA; always check the most recent tax guidance for details.

What is the latest dividend for Procter & Gamble stock?

Procter & Gamble currently pays a quarterly dividend. As of May 2025, the annual dividend amounts to $4.23 per share, with the most recent payment announced in April. This represents a yield of around 2.5%. P&G is renowned for its long history of increasing dividends, reflecting steady cash flow and a strong commitment to rewarding shareholders.

What is the forecast for Procter & Gamble stock in 2025, 2026, and 2027?

Based on recent valuations, the projected share price for Procter & Gamble is $219 at the end of 2025, $253 at the end of 2026, and $337 by the end of 2027. The company operates in a resilient consumer staples sector, supported by global brand leadership and continued product innovation. Analyst sentiment remains constructive, highlighting the stock’s underlying strengths.

Should I sell my Procter & Gamble shares?

Holding onto Procter & Gamble shares could be wise given the company’s defensive profile, solid dividend track record, and global portfolio of trusted brands. P&G’s ability to navigate challenging economic cycles and deliver steady results has historically reassured investors seeking stable growth. The stock’s fundamentals and sector positioning suggest it may remain a reliable choice for medium- to long-term portfolios.

How are Procter & Gamble dividends and capital gains taxed in Ireland?

For Irish residents, dividends from Procter & Gamble are subject to US withholding tax, typically at 15% if a tax treaty form is filed, and are also liable for Irish income tax. Capital gains from selling P&G shares are taxed under Irish Capital Gains Tax rules, with an annual exemption threshold. It's important to note that P&G shares are not eligible for Irish tax-free schemes like pensions or SSIA; always check the most recent tax guidance for details.

P. Laurore
P. Laurore
Finance expert
HelloSafe
Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.

Ask a question, an expert will answer